Akari Therapeutics Cash Flow Statement (2012-2025) | AKTX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-0.01B	-0.01B	-0.00B	-0.00B	-20.46B	-0.01B	-0.01B		-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)	-244.94B	0.00B	0.00B	237.60B	-237.60B	0.00B	0.00B		0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B
Deferred Taxes (Quarter)																			0.00B
Gains from Sales and Divestitures (Quarter)												0.04B	0.10B	0.38B	0.38B	0.64B		0.00B	0.00B	0.00B
Gains from Investment Securities (Quarter)					0.14B			0.51B		0.86B		0.00B	0.63B	-0.12B	-0.00B	6.81B	0.00B	19.17B	7.42B	0.00B
Asset Writedowns and Impairment (Quarter)																			0.01B
Non-cash Items (Quarter)	0.00B	-0.00B	-0.00B	-2206.46B		0.00B	-0.00B	0.13B				0.21B	0.24B	0.26B	2.00	0.00B	1.60B	0.00B	0.00B
Cash from Operations (Quarter)	12,717.27B	-0.01B	-0.00B	-13842.64B	13,842.66B	-0.01B	-0.01B		-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Amortization (Quarter)	0.00B				0.00B			0.00B
Depreciation & Amortization (CF) (Quarter)	0.00B								0.00B	0.00B	0.00B	0.00B	0.00B			0.00B
Change in Working Capital
Change in Account Payables (Quarter)
Change in Accured Expenses (Quarter)	2,076.71B	-0.00B	-0.00B	-1858.32B	1,858.32B	0.00B	-0.00B		-0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	-0.00B	-0.00B
Other Working Capital Changes (Quarter)												0.06B	0.02B	0.02B	0.04B	-0.00B			0.00B	-0.00B
Investing Activities
Capital Expenditures (Quarter)
Change in Intangibles (Quarter)		0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B		0.00B
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)
Financing Activities
Other financing activities (Quarter)													0.00B	0.00B	0.00B	-0.00B		0.00B
Cash from Financing Activities (Quarter)	-19081.43B			13,176.32B	-13176.32B	0.01B			0.00B	0.00B		0.00B	0.00B	0.01B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.01B
Debt Issuance and Repayment
Non-Current Debt (Quarter)
Additional items
Exchange Rate Effect (Quarter)	-221.93B	0.00B	-0.00B	-0.00B	-1.55B	-0.00B	-0.00B				-0.00B	0.00B	-0.00B	-0.00B	0.00B	0.00B			-0.00B
Change in Cash (Quarter)	-6586.10B	-0.01B	-0.00B	-664.78B	664.79B	0.01B	-0.01B		-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	-0.00B	0.00B	-0.00B	0.00B	-0.00B	0.00B
Beginning Cash Balance (Quarter)
Free Cash Flow (Quarter)	12,717.27B	-0.01B	-0.00B	-13842.64B	13,842.66B	-0.01B	-0.01B		-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Net Cash Flow (Quarter)	-6364.16B	-0.01B	-0.00B	-666.32B	666.33B	0.01B	-0.01B		-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	-0.00B	0.00B	-0.00B	0.00B	-0.00B	0.00B

Research Tools

Akari Therapeutics Cash Flow Statement (2012-2025) | AKTX

Create an account

Sign In

Reset Password